These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 33170119)
21. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center. de Almeida Silva KCF; Calomino MA; Deutsch G; de Castilho SR; de Paula GR; Esper LMR; Teixeira LA Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453 [TBL] [Abstract][Full Text] [Related]
22. Molecular detection of type III secretory toxins in Pseudomonas aeruginosa isolates. Jarjees KK Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):9-14. PubMed ID: 33040805 [TBL] [Abstract][Full Text] [Related]
23. An outbreak of fluoroquinolone-resistant Pseudomonas aeruginosa ST357 harboring the exoU gene. Kainuma A; Momiyama K; Kimura T; Akiyama K; Inoue K; Naito Y; Kinoshita M; Shimizu M; Kato H; Shime N; Fujita N; Sawa T J Infect Chemother; 2018 Aug; 24(8):615-622. PubMed ID: 29628388 [TBL] [Abstract][Full Text] [Related]
24. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. Gales AC; Menezes LC; Silbert S; Sader HS J Antimicrob Chemother; 2003 Oct; 52(4):699-702. PubMed ID: 12951331 [TBL] [Abstract][Full Text] [Related]
25. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm. Recio R; Villa J; Viedma E; Orellana MÁ; Lora-Tamayo J; Chaves F Int J Antimicrob Agents; 2018 Aug; 52(2):172-179. PubMed ID: 29621591 [TBL] [Abstract][Full Text] [Related]
26. High mortality of bloodstream infection outbreak caused by carbapenem-resistant P. aeruginosa producing SPM-1 in a bone marrow transplant unit. Chaves L; Tomich LM; Salomão M; Leite GC; Ramos J; Martins RR; Rizek C; Neves P; Batista MV; Amigo U; Guimaraes T; Levin AS; Costa SF J Med Microbiol; 2017 Dec; 66(12):1722-1729. PubMed ID: 29095142 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa. Tsao LH; Hsin CY; Liu HY; Chuang HC; Chen LY; Lee YJ J Microbiol Immunol Infect; 2018 Jun; 51(3):359-366. PubMed ID: 28988663 [TBL] [Abstract][Full Text] [Related]
29. Changing the epidemiology of carbapenem-resistant Pseudomonas aeruginosa in a Brazilian teaching hospital: the replacement of São Paulo metallo-β-lactamase-producing isolates. Cavalcanti FL; Almeida AC; Vilela MA; Morais MM; Morais Junior MA Mem Inst Oswaldo Cruz; 2012 May; 107(3):420-3. PubMed ID: 22510840 [TBL] [Abstract][Full Text] [Related]
30. Risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa: clinical impact of bacterial virulence and strains on outcome. Jeong SJ; Yoon SS; Bae IK; Jeong SH; Kim JM; Lee K Diagn Microbiol Infect Dis; 2014 Oct; 80(2):130-5. PubMed ID: 25112900 [TBL] [Abstract][Full Text] [Related]
31. Phenotypic and Molecular Survey of Metallo-beta-lactamase-producing Rouhi S; Ramazanzadeh R Infect Disord Drug Targets; 2020; 20(1):56-64. PubMed ID: 30659550 [TBL] [Abstract][Full Text] [Related]
32. Urinary tract infections caused by Pseudomonas aeruginosa among children in Southern Poland: Virulence factors and antibiotic resistance. Pobiega M; Maciag J; Pomorska-Wesolowska M; Chmielarczyk A; Romaniszyn D; Ziolkowski G; Heczko PB; Wojkowska-Mach J; Bulanda M J Pediatr Urol; 2016 Feb; 12(1):36.e1-6. PubMed ID: 26320394 [TBL] [Abstract][Full Text] [Related]
33. Characterization of carbapenem resistance mechanisms and integrons in Pseudomonas aeruginosa strains from blood samples in a French hospital. Rojo-Bezares B; Cavalié L; Dubois D; Oswald E; Torres C; Sáenz Y J Med Microbiol; 2016 Apr; 65(4):311-319. PubMed ID: 26838942 [TBL] [Abstract][Full Text] [Related]